In particular, IGHV-mutated CLL cells, associated with a favourable clinical prognosis and derived from the CD5+/CD27+ post-GC B-cell subset43 displayed significantly higher LMNB1 gene expression as compared with uCLL samples. This evidence concerns the gene LMNB1 and B-cell chronic lymphocytic leukemia.